Abstract
Purpose
Although fear of recurrence (FCR) is common among cancer survivors, it remains unclear what factors predict initial levels (e.g., prior to surgery) or changes in FCR in the post-treatment period. Among women treated for breast cancer, this study evaluated the effects of demographic, clinical, symptom, and psychosocial adjustment characteristics on the initial (preoperative) levels of FCR and trajectories of FCR over 6 months following surgery.
Methods
Prior to and for 6 months following breast cancer surgery, 396 women were assessed for demographic and clinical (disease and treatment) characteristics, symptoms, psychological adjustment characteristics, and quality of life (QOL). FCR was assessed using a four-item subscale from the QOL instrument. Hierarchical linear modeling was used to examine changes in FCR scores and to identify predictors of inter-individual differences in preoperative FCR levels and trajectories over 6 months.
Results
From before surgery to 6 months post-operatively, women with breast cancer showed a high degree of inter-individual variability in FCR. Preoperatively, women who lived with someone, experienced greater changes in spiritual life, had higher state anxiety, had more difficulty coping, or experienced more distress due to diagnosis or distress to family members reported higher FCR scores. Patients who reported better overall physical health and higher FCR scores at enrollment demonstrated a steeper decrease in FCR scores over time.
Conclusions
These findings highlight inter-individual heterogeneity in initial levels and changes in FCR over time among women undergoing breast cancer surgery. Further work is needed to identify and provide interventions for women experiencing FCR during and after breast cancer treatment.
Similar content being viewed by others
References
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7:300–322
Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241–251
Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D (2013) Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum 40:35–42
Brennan ME, Butow P, Spillane AJ, Boyle F (2014) Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning. Asia Pac J Clin Oncol. doi:10.1111/ajco.12254
Savard J, Ivers H (2013) The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res 74:354–360
Stanton AL, Danoff-Burg S, Huggins ME (2002) The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology 11:93–102
Vickberg SM (2003) The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med 25:16–24
Lee-Jones C, Humphris G, Dixon R, Hatcher MB (1997) Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 6:95–105
Tewari A, Chagpar AB (2014) Worry about breast cancer recurrence: a population-based analysis. Am Surg 80:640–645
Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Hopfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V (2014) Fear of recurrence in long-term breast cancer survivors—still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship—a multi-regional population-based study. Psychooncology 23:547–554
Simard S, Savard J, Ivers H (2010) Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv 4:361–371
Skaali T, Fossa SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, Klepp O, Oldenburg J, Wist E, Dahl AA (2009) Fear of recurrence in long-term testicular cancer survivors. Psychooncology 18:580–588
Simard S, Savard J (2009) Screening and comorbidity of clinical fear of cancer recurrence. Psychooncology 18(Suppl 2):S171
Hirai K, Shiozaki M, Motooka H, Arai H, Koyama A, Inui H, Uchitomi Y (2008) Discrimination between worry and anxiety among cancer patients: development of a Brief Cancer-Related Worry Inventory. Psychooncology 17:1172–1179
Lebel S, Rosberger Z, Edgar L, Devins GM (2009) Emotional distress impacts fear of the future among breast cancer survivors not the reverse. J Cancer Surviv 3:117–127
Llewellyn CD, Weinman J, McGurk M, Humphris G (2008) Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res 65:525–532
Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B (2006) Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 15:306–320
van den Beuken-van Everdingen MH, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J (2008) Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology 17:1137–1145
Dinkel A, Kremsreiter K, Marten-Mittag B, Lahmann C (2014) Comorbidity of fear of progression and anxiety disorders in cancer patients. Gen Hosp Psychiatry. doi:10.1016/j.genhosppsych.2014.08.006
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2009) Quality of life and non-pain symptoms in patients with cancer. J Pain Symptom Manag 38:216–233
Butow P, Kelly S, Thewes B, Hruby G, Sharpe L, Beith J (2014) Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. Psychooncology. doi:10.1002/pon.3659
McGinty HL, Goldenberg JL, Jacobsen PB (2012) Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psychooncology 21:203–210
Mehnert A, Berg P, Henrich G, Herschbach P (2009) Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology 18:1273–1280
Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB (2011) Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 130:165–173
Mehnert A, Koch U, Sundermann C, Dinkel A (2013) Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol 52:1102–1109
Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M, Capp A, Dalley D (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer 20:2651–2659
Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, New York
Dhruva A, Dodd M, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Swift PS, Wara W, Miaskowski C (2010) Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs 33:201–212
Langford DJ, Tripathy D, Paul SM, West C, Dodd MJ, Schumacher K, Miaskowski C (2011) Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain. J Pain 12:495–507
Lindviksmoen G, Hofso K, Paul SM, Miaskowski C, Rustoen T (2013) Predictors of initial levels and trajectories of depressive symptoms in women with breast cancer undergoing radiation therapy. Cancer Nurs 36:E34–E43
Huang HP, Chen ML, Liang J, Miaskowski C (2014) Changes in and predictors of severity of fatigue in women with breast cancer: a longitudinal study. Int J Nurs Stud 51:582–592
Kyranou M, Puntillo K, Dunn LB, Aouizerat BE, Paul SM, Cooper BA, Neuhaus J, West C, Dodd M, Miaskowski C (2014) Predictors of initial levels and trajectories of anxiety in women before and for 6 months after breast cancer surgery. Cancer Nurs 37(6):406–417. doi:10.1097/NCC.0000000000000131
Mellon S, Kershaw TS, Northouse LL, Freeman-Gibb L (2007) A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psychooncology 16:214–223
Miaskowski C, Cooper B, Paul SM, West C, Langford D, Levine JD, Abrams G, Hamolsky D, Dunn L, Dodd M, Neuhaus J, Baggott C, Dhruva A, Schmidt B, Cataldo J, Merriman J, Aouizerat BE (2012) Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain 13:1172–1187
Van Onselen C, Paul SM, Lee K, Dunn L, Aouizerat BE, West C, Dodd M, Cooper B, Miaskowski C (2013) Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer. J Pain Symptom Manag 45:244–260
Kyranou M, Paul SM, Dunn LB, Puntillo K, Aouizerat BE, Abrams G, Hamolsky D, West C, Neuhaus J, Cooper B, Miaskowski C (2013) Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery. Eur J Oncol Nurs 17:190–195
Dunn LB, Cooper BA, Neuhaus J, West C, Paul S, Aouizerat B, Abrams G, Edrington J, Hamolsky D, Miaskowski C (2011) Identification of distinct depressive symptom trajectories in women following surgery for breast cancer. Health Psychol 30:683–692
Karnofsky D, Abelmann WH, Craver LV, Burchenal JH (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656
Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49:156–163
Brunner F, Bachmann LM, Weber U, Kessels AG, Perez RS, Marinus J, Kissling R (2008) Complex regional pain syndrome 1—the Swiss cohort study. BMC Musculoskelet Disord 9:92
Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45:5–13
Sheehan TJ, Fifield J, Reisine S, Tennen H (1995) The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess 64:507–521
Fletcher BS, Paul SM, Dodd MJ, Schumacher K, West C, Cooper B, Lee K, Aouizerat B, Swift P, Wara W, Miaskowski CA (2008) Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol 26:599–605
Spielberger CG, Gorsuch RL, Suchene R, Vagg PR, Jacobs GA (1983) Manual for the state-anxiety (form Y): Self Evaluation Questionnaire. Consulting Psychologists Press, Palo Alto
Bieling PJ, Antony MM, Swinson RP (1998) The state-trait anxiety inventory, trait version: structure and content re-examined. Behav Res Ther 36:777–788
Jensen MP (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4:2–21
Ferrell BR, Wisdom C, Wenzl C (1989) Quality of life as an outcome variable in the management of cancer pain. Cancer 63:2321–2327
Padilla GV, Presant C, Grant MM, Metter G, Lipsett J, Heide F (1983) Quality of life index for patients with cancer. Res Nurs Health 6:117–126
Waldrop DP, O’Connor TL, Trabold N (2011) “Waiting for the other shoe to drop:” distress and coping during and after treatment for breast cancer. J Psychosoc Oncol 29:450–473
Raudenbush SW, Bryk AS (2002) Hierarchical linear models: applications and data analysis methods. Sage Press, Thousand Oaks
Enders CK (2010) Applied missing data analysis. Guilford Press, New York
Lebel S, Beattie S, Ares I, Bielajew C (2013) Young and worried: age and fear of recurrence in breast cancer survivors. Health Psychol 32:695–705
Ziner KW, Sledge GW, Bell CJ, Johns S, Miller KD, Champion VL (2012) Predicting fear of breast cancer recurrence and self-efficacy in survivors by age at diagnosis. Oncol Nurs Forum 39:287–295
Thewes B, Bell ML, Butow P (2013) Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psychooncology 22:2059–2063
Heitzmann CA, Merluzzi TV, Jean-Pierre P, Roscoe JA, Kirsh KL, Passik SD (2011) Assessing self-efficacy for coping with cancer: development and psychometric analysis of the brief version of the Cancer Behavior Inventory (CBI-B). Psychooncology 20:302–312
Philip EJ, Merluzzi TV, Zhang Z, Heitzmann CA (2013) Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors. Psychooncology 22:987–994
Benight CC, Bandura A (2004) Social cognitive theory of posttraumatic recovery: the role of perceived self-efficacy. Behav Res Ther 42:1129–1148
Chesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S (2006) A validity and reliability study of the coping self-efficacy scale. Br J Health Psychol 11:421–437
Lebel S, Maheu C, Lefebvre M, Secord S, Courbasson C, Singh M, Jolicoeur L, Benea A, Harris C, Fung MF, Rosberger Z, Catton P (2014) Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 8:485–496
Herschbach P, Book K, Dinkel A, Berg P, Waadt S, Duran G, Engst-Hastreiter U, Henrich G (2010) Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer 18:471–479
Lengacher CA, Shelton MM, Reich RR, Barta MK, Johnson-Mallard V, Moscoso MS, Paterson C, Ramesar S, Budhrani P, Carranza I, Lucas J, Jacobsen PB, Goodman MJ, Kip KE (2012) Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med 37(2):185–195
Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M, Goodman M, Cox CE, Kip KE (2009) Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology 18:1261–1272
Butow PN, Bell ML, Smith AB, Fardell JE, Thewes B, Turner J, Gilchrist J, Beith J, Girgis A, Sharpe L, Shih S, Mihalopoulos C (2013) Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer 13:201
Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J (2006) Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 44:1–25
Acknowledgments
This study was funded by grants from the National Cancer Institute (NCI) (CA107091, CA118658) and was supported by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131. Dr. Miaskowski is supported by a grant from the NCI (K05 CA168960) and is an American Cancer Society Clinical Research Professor. Dr. Langford is supported by a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship (W81XWH-11-1-0719). Dr. Merriman is supported by a training grant from the NINR (T32 NR011972). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Conflict of interest
The authors have no conflicts of interest to disclose. We have full control of all primary data and agree to allow the journal to review our data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dunn, L.B., Langford, D.J., Paul, S.M. et al. Trajectories of fear of recurrence in women with breast cancer. Support Care Cancer 23, 2033–2043 (2015). https://doi.org/10.1007/s00520-014-2513-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2513-8